ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc (0LIF)

64.79
0.00
(0.00%)
Closed March 02 10:30AM

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 490.75M719.56M1.14B1.76B1.52B1.55B1.49B1.5B
Total Current Assets 269.58M522.37M851.02M1.3B856.6M883.9M732.18M817.12M
Cash and Equivalents 100.49M113.43M433.58M713.53M307.58M132.94M213.58M173.73M
Total Non-Current Assets 383.45M608.91M653.76M1.15B922.56M352.49M275.41M255.3M
Total Liabilities 107.3M110.65M481.73M605.18M599.84M1.19B1.22B1.24B
Total Current Liabilities 71.01M74.73M103.3M189.61M181.37M261.21M280.44M344.15M
Total Non-Current Liabilities 36.29M35.93M378.43M751.94M770.66M1.81B1.8B1.72B
Total Equity 383.45M608.91M653.76M1.15B922.56M352.49M275.41M255.3M
Common Equity 44k51k58k67k69k70k82k92k
Retained Earnings -832.67M-1.03B-1.43B-1.62B-2.07B-2.78B-3.39B-3.96B